Sanofi's Sarclisa Becomes First EU-Approved Anticancer Therapy Via On-Body Injector, Covering All Four Existing Multiple Myeloma Indications

뉴스 본문을 불러오고 있어요.

Sanofi's Sarclisa Becomes First EU-Approved Anticancer Therapy Via On-Body Injector, Covering All Four Existing Multiple Myeloma Indications | 웨이프 WAPE

Sanofi's Sarclisa Becomes First EU-Approved Anticancer Therapy Via On-Body Injector, Covering All Four Existing Multiple Myeloma Indications

기사 요약

관련 종목

댓글 —